Radiopharm Theranostics

RADX

ASX - ALL MARKETSHealth Care

Income Statement

Total Revenue$1.68M

Operating Income$0

EBITDA$0

EBIT$-78.9M

Pre-tax Income$-89.46M

Net Income$-88.73M

Net Cash$364.37M

Cash Equivalent$36.44M

Total Debt$0

Net Debt$-364.37M

Book Value$28.12

Net Cash Per Share170000.00

Book Value Per Share0.06

Return on Equity (ROE)-170.50%

Return on Assets (ROA)-66.56%

Return on Invested Capital (ROI)-170.50%

Net Profit Margin-16024.17%

Current Ratio1.30

Quick Ratio1.30

Long-Term Debt / Equitynull